-Down to Earth Shortage of antiretroviral drugs and lack of diagnosis is not new in India, but government does not admit to the crisis The fight against HIV/AIDS in India is becoming tougher by the day as patients continue to face an acute shortage of antiretroviral drugs. This is an alarming situation for a country with the third-highest number of HIV+ people in the world-2.1 million. In 2012, about 140,000 people in...
More »SEARCH RESULT
Total Matching Records found : 163
24% of global missed TB cases in India: WHO -Kounteya Sinha
-The Times of India LONDON: One in every four missed cases of tuberculosis (TB) globally is in India.The World Health Organisation has found that India tops the list of the world's missed TB cases. Almost 24% of the world's missed TB cases are from India, according to the Global TB Report 2014 released on Thursday. Ten countries accounted for 74% (2.4 million) of the estimated "missed" cases globally in 2013. The number of...
More »Mala Fide Decision on Drug Prices
-Economic and Political Weekly The decision to reduce the powers of the drug pricing body goes against the interest of public health. The decision of the Government of India to withdraw the power of the National Pharmaceutical Pricing Authority (NPPA) to set price controls on drugs that are not on the National List of Essential Medicines (NLEM) raises questions on the Narendra Modi regime's commitment to people's welfare. One must ask if...
More »For public health as political priority -Sujatha Rao
-The Hindu A systemic reform of the health sector in order to meet the key objectives of equity, efficiency and quality is long overdue. In this, the Central and State governments need to make interventions intelligently, decisively and strategically so that the poor reap the benefits How does Prime Minister Narendra Modi's focus on population, health and subjects like public hygiene, the facilitation of toilets and ensuring preventive health through yoga fit...
More »New hepatitis cure far too costly -Martin Khor
-Asia News Network A controversy is brewing over a new cure for hepatitis C because it is extremely expensive and patients in middle-income countries like Malaysia will find it way beyond their budget. There are an estimated 400,000 Malaysians with hepatitis C, but this is probably a significant under-estimate since many people are not aware that they have the virus. Worldwide, 170 million people live with the hepatitis C virus (HCV), and every...
More »
